Navigation Links
SuperGen in Medical News

SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results

... DUBLIN, Calif., March 2 /PRNewswire-FirstCall/ -- supergen Inc., (Nasdaq: SUPG ), a pharmaceutical company ..., representing approximately 1.5 million shares of supergen common stock. December 2008: The...employees. Conference Call Information supergen will host a conference call to discuss the results...

SuperGen to Announce 2008 Fourth Quarter and Fiscal Year-End Financial Results March 2, 2009

...eplay and conference call replay will be available for 90 days. About supergen Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. supergen is developing a number of therapeutic anticancer products focused on kinase...

SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009

...t www.supergen.com . The webcast will be archived for 90 days. About supergen Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. supergen is developing a number of therapeutic anticancer products focused on kinase...

SuperGen to Present at the Collins Stewart Growth Conference on July 9, 2008

...armaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For mo...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...aq: OREX ) Repros Therapeutics Inc. (Nasdaq: RPRX ) Sangamo BioSciences Inc. (Nasdaq: SGMO ) Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT ) supergen Inc. (Nasdaq: SUPG ) Transition Therapeutics Inc. (Nasdaq: TTHI ) XOMA Ltd. (Nasdaq: XOMA ) Neuroscience Index (HHN) Drop Neurochem Inc. (...

Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme

... DUBLIN, Calif., Oct. 31 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de... be a key player in this resistance. Scientists at supergen found that MP470 inhibits these kinases and data p...ignificant unmet clinical need in oncology. About supergen Based in Dublin, Calif.,...

SuperGen Reports 2007 Third Quarter Financial Results

... DUBLIN, Calif., Oct. 29 /PRNewswire-FirstCall/ -- supergen Inc., (Nasdaq: SUPG ), a pharmaceutical company d...itioned to David S. Smith, Ph.D., who joined supergen in March 2007 as Vice President, Regulatory and ...Consumer Healthcare. Conference Call Information supergen will host a conference call to discuss the results...

SuperGen to Announce 2007 Third Quarter Financial Results October 29, 2007

... DUBLIN, Calif., Oct. 22 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de...ference call will be available for 90 days. About supergen Based in Dublin, Calif., SuperGen, Inc. is a phar...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference

... DUBLIN, Calif., Oct. 17 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de... malignancies About supergen Based in Dublin, Calif., SuperGen, Inc. is a phar...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...
SuperGen in Medical Technology

SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia

... DUBLIN, Calif., Dec. 8 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company d...f Pennsylvania support this hypothesis." supergen recently received clearance for a phase I trial wi...ell as several types of leukemias. About supergen Based in Dublin, Calif., SuperGen, Inc. is a ...

SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

... DUBLIN, Calif., July 1 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG), a pharmaceutical company dedi...n was developed through a pivotal Phase 3 study by supergen and partnered to MGI PHARMA, INC. (acquired by Eis...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation

... DUBLIN, Calif., June 16 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de...ner, Manager of Discovery Biology, highlighted how supergen scientists used the company's CLIMB(TM) technology...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen's PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models

... DUBLIN, Calif., June 13 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery,...ercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase...

SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models

... DUBLIN, Calif., April 16 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery,...ercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase...

Data Show SuperGen's MP-470 is Safe in Humans

... DUBLIN, Calif., April 15 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery,...ercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase...

SuperGen's DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine

...DUBLIN, Calif., April 14 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de....com . About SuperGen Based in Dublin, Calif., supergen Inc. is a pharmaceutical company dedicated to the ...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib

...g erlotinib resistance DUBLIN, Calif., April 14 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery,...ercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase...

SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting

... DUBLIN, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery,...ercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase...

SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor

...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...mation, future events or otherwise. Contacts: supergen Timothy L. Enns S.V.P., Corporate Communications...evelopment (925) 560-0100 tenns@supergen.com supergen Mary M. Vegh Manager, Investor Relations (925) ...
SuperGen in Biological Technology

Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer

Dr. David S. Smith to Head Regulatory and Quality Affairs DUBLIN, Calif., Aug. 17 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malign...

SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor

..., representing approximately 1.5 million shares of supergen common stock. supergen will initiate a Phase I clinical trial to evaluate...as several types of human leukemias. About supergen Based in Dublin, Calif., SuperGen, Inc. is...

SuperGen Reports 2008 Third Quarter Financial Results

...act 571: Modulation of JAK2 signaling pathways in vitro and in vivo by SGI-1252, a small molecule JAK2 inhibitor. Conference Call Information supergen will host a conference call to discuss the 2008 third quarter financial results today at 1:30 p.m. PT / 4:30 p.m. ET. The webcast will be accessible v...

SuperGen to Announce 2008 Third Quarter Financial Results November 4, 2008

... DUBLIN, Calif., Oct. 28 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery ... will be available for 90 days. About SuperGen Based in Dublin, Calif., supergen Inc. is a pharmaceutical company dedicated to the discovery and development...

SuperGen's MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy

... drug designation for GBM, an often fatal form of brain cancer, can entitle supergen to seven years of market exclusivity. SuperGen's lead product candidate has...e spectrum of cancers, including non-small cell lung cancer. Furthermore, supergen presented four additional posters at the Symposium that reviewed clinical a...

SuperGen Reports 2008 Second Quarter Financial Results

...nager of Discovery Biology, highlighted how supergen scientists used the Company's CLIMB technology to ... scientific forum. Conference Call Information supergen will host a conference call to discuss the results...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008

...armaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For mo...

SuperGen Reports 2008 First Quarter Financial Results

...DUBLIN, Calif., April 28 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ) today reported financial res...red to decitabine. Conference Call Information supergen will host a conference call to discuss the results...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen to Webcast 3rd Annual Analyst Day on April 29, 2008

...DUBLIN, Calif., April 22 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de...event. About SuperGen Based in Dublin, Calif., supergen Inc. is a pharmaceutical company dedicated to the ...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...

SuperGen to Announce 2008 First Quarter Financial Results April 28, 2008

...DUBLIN, Calif., April 21 /PRNewswire-FirstCall/ -- supergen Inc. (Nasdaq: SUPG ), a pharmaceutical company de... days. About SuperGen Based in Dublin, Calif., supergen Inc. is a pharmaceutical company dedicated to the ...s for solid tumors and hematological malignancies. supergen is developing a number of therapeutic anticancer p...
Other Tags
(Date:7/29/2014)... WA (PRWEB) July 29, 2014 Award-winning inventor ... , a flatulence neutralizer specifically designed to absorb embarrassing odors ... charcoal that can easily be stored in a desk drawer. ... use the PoofPad, users will simply sit on the pad ... gas at the office and then BAM, someone appears out ...
(Date:7/29/2014)... 2014 Riverdale Urgent Care is making ... Through their presence at local events, partnerships and other ... than just a medical service for the Riverdale neighborhood. ... in support of Riverdale RiverFest and South Riverdale Street ... features local musicians and entertainers, arts and crafts, boat ...
(Date:7/29/2014)... July 29, 2014 Lean and Lovely, an ... for women who want to wear a bikini in the ... Stevenson, prompting an investigative review. , “Our Lean and ... for women at all fitness levels. Neither your age nor ... unfit your body is at the beginning, you will achieve ...
(Date:7/29/2014)... Current Back2Basics long-term drug rehab resident Jon B. ... his first six months of sobriety. , This was ... foot, once on the other– which was how he became ... ago and was prescribed drugs that I didn’t take properly.” ... home who’d recently completed the program. The six-month long residential ...
(Date:7/29/2014)... 29, 2014 PeopleKeys today announced that ... teach students how to train and certify others in ... Behavioral Consultant Trainer , will be taught by PeopleKeys ... Training John Schindell as a live Tele-course over the ... The Certified Behavioral Consultant Trainer course will use a ...
Breaking Medicine News(10 mins):Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 3Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 2Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 3Health News:Lean and Lovely: Review Examining Neghar Fonooni’s Program Released 2Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3
(Date:7/27/2014)... might have survived the asteroid strike that wiped them ... later in history, scientists say. , A fresh study ... helped palaeontologists to build a new narrative of the ... They found that in the few million years before ... was experiencing environmental upheaval. This included extensive volcanic activity, ...
(Date:7/27/2014)... have shown the potential for global climate change to ... most part, ignored the interactions between increasing temperature and ... to damage crops. , A new study involving researchers ... significant, suggesting that policymakers need to take both warming ... , The study looked in detail at global production ...
(Date:7/25/2014)... the first broad-scale estimate of air pollution removal by ... that trees are saving more than 850 human lives ... symptoms. , While trees, pollution removal equated to an ... the impacts of that improvement are substantial. Researchers valued ... at nearly $7 billion every year in a study ...
Breaking Biology News(10 mins):Dinosaurs fell victim to perfect storm of events, study shows 2Study: Climate change and air pollution will combine to curb food supplies 2Study: Climate change and air pollution will combine to curb food supplies 3First national study finds trees saving lives, reducing respiratory problems 2
Other Contents